We are live on ! Find out more
WC

Wexford Capital Portfolio holdings

AUM $690M
1-Year Est. Return 57.88%
This Fund
S&P 500
This Quarter Est. Return
+49.29%
1 Year Est. Return
+57.88%
3 Year Est. Return
+92.56%
5 Year Est. Return
10 Year Est. Return
AUM
$639M
AUM Growth
+$265M
Cap. Flow
+$133M
Cap. Flow %
20.86%
Top 10 Hldgs %
40.09%
Holding
399
New
225
Increased
43
Reduced
24
Closed
95

Sector Composition

Rank Sector Weight
1 Industrials 26.1%
2 Consumer Discretionary 14.26%
3 Energy 12.99%
4 Healthcare 11.88%
5 Utilities 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTT
276
DELISTED
GTT Communications, Inc.
GTT
$38K 0.01%
+10,584
New +$45.7K
CXW icon
277
CoreCivic
CXW
$3.19B
$37K 0.01%
+5,589
New +$40.2K
MRKR icon
278
Marker Therapeutics
MRKR
$18.7M
$37K 0.01%
+2,586
New +$40.1K
PAYS icon
279
Paysign
PAYS
$693M
$37K 0.01%
+8,032
New +$42K
WTI icon
280
W&T Offshore
WTI
$504M
$37K 0.01%
+17,133
New +$33K
ICPT
281
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$37K 0.01%
+1,485
New +$49.2K
ROCC
282
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$37K 0.01%
+3,693
New +$34.8K
ADMA icon
283
ADMA Biologics
ADMA
$2.25B
$36K 0.01%
+18,605
New +$39.1K
NERV icon
284
Minerva Neurosciences
NERV
$207M
$36K 0.01%
+1,934
New +$48.7K
SVRA icon
285
Savara
SVRA
$1.19B
$36K 0.01%
+31,253
New +$37.7K
CLVS
286
DELISTED
Clovis Oncology, Inc.
CLVS
$36K 0.01%
+7,568
New +$38.3K
EPIX
287
DELISTED
ESSA Pharma
EPIX
$35K 0.01%
2,950
-20,050
-87% -$141K
YARW
288
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
$35K 0.01%
+6
New +$37.7K
ABTC
289
American Bitcoin Corp
ABTC
$451M
0
EXPR
290
DELISTED
Express, Inc.
EXPR
$34K 0.01%
+1,843
New +$34.8K
AMC icon
291
AMC Entertainment Holdings
AMC
$2.29B
$32K 0.01%
+1,510
New +$49.4K
CRBP icon
292
Corbus Pharmaceuticals
CRBP
$180M
$32K 0.01%
+852
New +$31.9K
EOLS icon
293
Evolus
EOLS
$489M
$31K ﹤0.01%
+9,261
New +$34.8K
GILD icon
294
Gilead Sciences
GILD
$162B
$29K ﹤0.01%
500
SEAH
295
DELISTED
Sports Entertainment Acquisition Corp.
SEAH
$21K ﹤0.01%
+2,049
New +$20.5K
SPRQ.U
296
DELISTED
Spartan Acquisition Corp. II Units, each consisting of one share of Class A common stock, and one-ha
SPRQ.U
$21K ﹤0.01%
+1,915
New +$20.2K
VIEW
297
DELISTED
View, Inc. Class A Common Stock
VIEW
$20K ﹤0.01%
+30
New +$18.6K
IIIIU
298
DELISTED
INSU Acquisition Corp. III Unit
IIIIU
$20K ﹤0.01%
+1,916
New +$20.3K
SLNO
299
DELISTED
Soleno Therapeutics
SLNO
$19K ﹤0.01%
667
-690
-51% -$19.9K
LOGC
300
DELISTED
ContextLogic
LOGC
$18K ﹤0.01%
+33
New +$20.4K

Similar funds

Wexford Capital's Q4 2020 Portfolio in Review

As of Q4 2020, Wexford Capital held 399 positions worth $639M, up 71% from $374M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Wexford Capital deployed $133M of net new capital in Q4 2020, opening 225 new positions and adding to 43 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 85,255 shares worth $16.7M.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Energy.

On the sell side, the largest reduction was T-Mobile US, an estimated $10M trimmed.

  • Wexford Capital's largest Q4 2020 buy was iShares Russell 2000 ETF: 85,255 shares worth $16.7M.
  • Wexford Capital added most to Expedia Group in Q4 2020, an estimated $12.3M increase.
  • Wexford Capital's biggest Q4 2020 reduction was T-Mobile US, cutting an estimated $10M.
  • Wexford Capital fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2020, selling an estimated $13.2M.
  • Wexford Capital's ten largest holdings make up 40% of its $639M portfolio in Q4 2020.
  • Wexford Capital opened 225 new positions and closed 95 in Q4 2020.
  • Wexford Capital's portfolio value rose 71% quarter-over-quarter to $639M.

Based on Wexford Capital's 13F filing for Q4 2020, filed 16 Feb 2021.